Fundraising Fox
/Companies
Sign in

Indevr

Boulder, US · Delaware corporation · 1 known investors

Find your way into Indevr

Sign up to see every warm intro you have to Indevr

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Indevr team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

InDevR develops off-the-shelf and custom analytical testing solutions, including its VaxArray microarray platform and multiplex immunoassays, for the development, optimization, and manufacturing of mRNA-, protein-, polysaccharide, conjugate, and viral vector-based vaccines. It serves vaccine developers and manufacturers with GMP- and 21 CFR Part 11-compliant assays used across R&D, clinical trials, and release testing.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

KRKathy Rowlen
Kathy RowlenFounder · CEO2008–2026Kathy Rowlen is a former chemistry professor at the University of Colorado Boulder with expertise in analytical chemistry and spectroscopy. She co-founded InDevR and served as its CEO before transitioning to a scientific advisor role, focusing on translating analytical chemistry into practical solutions for vaccine development and biomanufacturing.
SRShannon Rodriguez
Shannon RodriguezChief Operations Officer
ED
Erica DawsonChief Research and Development OfficerErica Dawson is Chief Technical Officer at InDevR, where she leads product development and team management across the company's vaccine analytical testing platforms. She has experience in instrument development, immunoassay platform development, and technical program management in the life sciences sector.
CHCraig Hoechstetter
Craig HoechstetterChief Commercial OfficerChief Commercial Officer of InDevR, a provider of analytical testing solutions for vaccine development and manufacturing. Hoechstetter brings experience in sales, marketing, business development, and operations across life sciences, environmental sciences, chemicals, and clinical diagnostics sectors.
MC
Michael ChangNamed on SEC filing
LK
Laura KuckNamed on SEC filing

Board

GRGlenn Rockman
Glenn RockmanDirector2019–2022Co-Founder and Partner at Adjuvant Capital

Investors · 1

Reported raises · per SEC filings

Form D private placements

$10M disclosed across 2 rounds · 2019–2022

▶$6MraisedJan 2023 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ChangDirector
  • Shannon RodriguezExecutive Officer, Director, Promoter
  • Kathy RowlenExecutive Officer, Director, Promoter
  • Michael ReynierDirector
  • Erica DawsonExecutive Officer
Offering amount
$9M
Amount sold
$6M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedSep 2019 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael ChangDirector
  • Kathy RowlenExecutive Officer, Director, Promoter
  • Shannon RodriguezExecutive Officer, Director, Promoter
  • Laura KuckExecutive Officer
  • Erica DawsonExecutive Officer
  • Glenn RockmanDirector
Offering amount
$7M
Amount sold
$4M
First sale
Aug 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Indevr went on to found or lead other companies.

Rose NashScientistFounded BiotaJen Baird, NACD.DCBusiness AdvisorFounded Fifth Eye

Frequently asked questions

What does Indevr do?
InDevR develops off-the-shelf and custom analytical testing solutions, including its VaxArray microarray platform and multiplex immunoassays, for the development, optimization, and manufacturing of mRNA-, protein-, polysaccharide, conjugate, and viral vector-based vaccines. It serves vaccine developers and manufacturers with GMP- and 21 CFR Part 11-compliant assays used across R&D, clinical trials, and release testing.
Who founded Indevr?
Indevr was founded by Kathy Rowlen.
Who are Indevr's investors?
Indevr's investors include Adjuvant Capital.
How much funding has Indevr raised?
Indevr has disclosed $10M raised across 2 rounds.
Where is Indevr headquartered?
Indevr is headquartered in Boulder, US.